The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

VRP VERONA PHARMA PLC ORD 0.1P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
14:47 10-Feb-2016 VRP Grant of Share Options PRN -0.75% Down
12:24 21-Jan-2016 VRP Director Dealing RNS +11.92% Up
07:00 11-Jan-2016 VRP Directorate Change PRN -4.33% Down
16:02 03-Dec-2015 VRP Director Dealing PRN +4.48% Up
17:11 01-Dec-2015 VRP Holding(s) in Company RNS +2.07% Up
07:00 11-Nov-2015 VRP RPL554 paper published in American Journal of Physiology PRN -4.24% Down
07:00 05-Nov-2015 VRP Patient enrolment completed in RPL554 PhIIa studies PRN -3.63% Down
07:00 14-Oct-2015 VRP Start of RPL554 Phase IIa combination study PRN -
11:30 08-Oct-2015 VRP RPL554 data presented at North American CF Conference PRN -10.46% Down
07:00 29-Sep-2015 VRP Positive headline data from RPL554 study PRN +7.00% Up
07:00 08-Sep-2015 VRP Half-yearly Report PRN -9.79% Down
07:00 08-Sep-2015 VRP Board Changes PRN -9.79% Down
07:00 27-Aug-2015 VRP Notice of Results PRN +4.05% Up
16:45 07-Jul-2015 VRP Director Dealing PRN -6.58% Down
17:02 17-Jun-2015 VRP Director Dealings PRN -7.32% Down
07:00 12-Jun-2015 VRP Secondary listing in Germany PRN +3.76% Up
13:00 11-Jun-2015 VRP Result of AGM PRN +10.26% Up
07:00 11-Jun-2015 VRP RPL554 Phase 2a trial started PRN +10.26% Up
07:00 08-Jun-2015 VRP RPL554 MAD study complete PRN +31.11% Up
14:36 18-May-2015 VRP Director/PDMR Shareholding RNS +23.25% Up

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address 3 More London Riverside, London, SE1 2RE, United Kingdom
Company website http://www.veronapharma...
Market cap(in millions)* £ 33.33
Listing/Admission to trading 19 Sep 2006
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
11-Feb-16
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AIM
MiFID Status MTF
Exchange market size 30,000
SEDOL B06GSH4
ISIN number GB00B06GSH43



VERONA PHARMA share news analysis (VRP)